dbl™ dobutamine hydrochloride
pfizer new zealand limited - dobutamine hydrochloride 12.5 mg/ml - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 12.5 mg/ml excipient: sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. (refer to the data sheet for conditions which may precipitate such situations).
sterile dobutamine hydrochloride concentrate
hospira uk limited - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml - dobutamine
dobutamine 250mg/50ml solution for infusion vials
hameln pharma ltd - dobutamine hydrochloride - solution for infusion - 5mg/1ml
simdax
orion pharma (nz) limited - levosimendan 2.5 mg/ml - concentrate for infusion - 2.5 mg/ml - active: levosimendan 2.5 mg/ml excipient: citric acid ethanol povidone - simdax is indicated for the short-term treatment of acutely decompensated chronic heart failure (adhf) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate.
normiten 100
teva pharmaceutical industries ltd, israel - atenolol - tablets - atenolol 100 mg - atenolol - atenolol - management of angina pectoris and hypertension,including hypertension of renal origin. late intervention after acute myocardial infarction.
normiten 50
abic ltd. - atenolol - tablets - atenolol 50 mg - atenolol - atenolol - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction
normiten 25
abic ltd. - atenolol - tablets - atenolol 25 mg - beta blocking agents, selective - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction.
dobutamine 12.5mg/ml concentrate for solution for infusion
mercury pharmaceuticals (ireland) ltd - dobutamine hydrochloride - concentrate for solution for infusion - 12.5 milligram(s)/millilitre - dobutamine
dobutamine 12.5 mg/ml concentrate for soln for inf
claris lifesciences (uk) limited - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml - adrenergic and dopaminergic agents
concor tablet 2.5 mg
merck pte. ltd. - bisoprolol fumarate - tablet, film coated - 2.5 mg - bisoprolol fumarate 2.5 mg